Parenchymal Extinction Mimicking Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B-Related Liver Cirrhosis

被引:1
|
作者
Kang, Min Kyu [1 ]
Choi, Joon Hyuk [2 ]
机构
[1] Yeungnam Univ, Coll Med, Dept Internal Med, 170 Hyunchungro, Daegu 42415, South Korea
[2] Yeungnam Univ, Coll Med, Dept Pathol, 170 Hyunchungro, Daegu 42415, South Korea
基金
新加坡国家研究基金会;
关键词
parenchymal extinction; hepatocellular carcinoma; alpha-fetoprotein; dynamic T1-weighted MRI scan; DIAGNOSIS; CANCER; BIOPSY;
D O I
10.3390/diagnostics11071171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parenchymal extinction is characterized by the irreversible loss of hepatocytes and their eventual replacement by fibrous tissue, along with the alteration of the sinusoidal architecture and the obstruction of the small portal and hepatic veins. In clinical practice, radiologic modalities are not sufficient for differentiating between parenchymal extinction and hepatocellular carcinoma in patients with advanced fibrosis or cirrhosis. Herein, we present a case of parenchymal extinction mimicking hepatocellular carcinoma in a patient with chronic hepatitis B-related liver cirrhosis.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Liver function and energy metabolism in hepatocellular carcinoma developed in patients with hepatitis B-related cirrhosis
    Ren, Meixin
    Li, Juan
    Xue, Ran
    Wang, Zhongying
    Li, Shengli
    Meng, Qinghua
    [J]. MEDICINE, 2019, 98 (19)
  • [2] Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
    Yu, MW
    Chang, HC
    Chen, PJ
    Liu, CJ
    Liaw, YF
    Lin, SM
    Lee, SD
    Lin, SC
    Lin, CL
    Chen, CJ
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (05) : 1008 - 1015
  • [3] Hepatitis B-related hepatocellular carcinoma is seen primarily in cirrhosis in an Australian cohort
    Sinclair, M.
    Roberts, S.
    Knight, V.
    Dev, A.
    Gow, P.
    Arachchi, N. J.
    Bell, S.
    Lim, L.
    Kemp, W.
    Philpott, H.
    Gorelik, A.
    Kronborg, I.
    Nicoll, A.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A125 - A125
  • [4] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis
    Huang, Rui
    Liu, Jiacheng
    Wang, Jian
    Wu, Chao
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1040 - 1041
  • [5] Entecavir versus tenofovir disoproxil fumarate on the reduction of incidence of hepatocellular carcinoma in patients with chronic hepatitis B-related liver cirrhosis
    Lin, Yu-Hung
    Lai, Huang-Lun
    Wang, Chun-Hsiang
    Chang, Kuo-Kuan
    Mo, Lein-Ray
    Lin, Ruey-Chang
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2024, 11 (01) : 16 - 23
  • [6] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
    Qiang Wei
    Xiao Xu
    Qi Ling
    Bo Zhou
    Shu-Sen Zheng
    [J]. Hepatobiliary & Pancreatic Diseases International, 2013, 12 (03) : 251 - 255
  • [7] the prevention of hepatitis B-related hepatocellular carcinoma
    Lin, C. -L.
    Kao, J. -H.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 5 - 14
  • [8] Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma
    Wei, Qiang
    Xu, Xiao
    Ling, Qi
    Zhou, Bo
    Zheng, Shu-Sen
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2013, 12 (03) : 251 - 255
  • [9] Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma
    Jianhua Yin
    Jiaxin Xie
    Hongwei Zhang
    Qiuxia Shen
    Lei Han
    Wenying Lu
    Yifang Han
    Chengzhong Li
    Wu Ni
    Hongyang Wang
    Guangwen Cao
    [J]. Journal of Gastroenterology, 2010, 45 : 1063 - 1071
  • [10] Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
    Cheng, Ran
    Xu, Xiaoyuan
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 987 - 997